CA2326952A1 - Tyrosine-phosphatase de proteines de cellules t - Google Patents
Tyrosine-phosphatase de proteines de cellules t Download PDFInfo
- Publication number
- CA2326952A1 CA2326952A1 CA002326952A CA2326952A CA2326952A1 CA 2326952 A1 CA2326952 A1 CA 2326952A1 CA 002326952 A CA002326952 A CA 002326952A CA 2326952 A CA2326952 A CA 2326952A CA 2326952 A1 CA2326952 A1 CA 2326952A1
- Authority
- CA
- Canada
- Prior art keywords
- tcptp
- cell
- cells
- protein
- jak
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03048—Protein-tyrosine-phosphatase (3.1.3.48)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002326952A CA2326952A1 (fr) | 2000-11-27 | 2000-11-27 | Tyrosine-phosphatase de proteines de cellules t |
PCT/CA2001/001679 WO2002042489A1 (fr) | 2000-11-27 | 2001-11-27 | Methodes faisant intervenir la proteine tyrosine phosphatase de lymphocyte t |
AU2002220412A AU2002220412A1 (en) | 2000-11-27 | 2001-11-27 | Methods involving a t cell protein tyrosine phosphatase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002326952A CA2326952A1 (fr) | 2000-11-27 | 2000-11-27 | Tyrosine-phosphatase de proteines de cellules t |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2326952A1 true CA2326952A1 (fr) | 2002-05-27 |
Family
ID=4167752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002326952A Abandoned CA2326952A1 (fr) | 2000-11-27 | 2000-11-27 | Tyrosine-phosphatase de proteines de cellules t |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002220412A1 (fr) |
CA (1) | CA2326952A1 (fr) |
WO (1) | WO2002042489A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0317099A (pt) | 2002-12-09 | 2005-10-25 | Boardd Of Regents Of The Unive | Método in vitro para inibir a função e/ou proliferação de uma janus tirosina quinase 3, método de teste in vitro para auxiliar na identificação de substâncias que são úteis como imunossupressores terapêuticos, método in vitro para auxiliar na identificação de um novo medicamento imunossupressor, método in vitro para inibir a função e/ou proliferação de uma célula expressando a janus tirosina quinase 3, uso de pelo menos um composto, composto quìmico isolado ou purificado e composição farmacêutica |
WO2008060540A2 (fr) * | 2006-11-13 | 2008-05-22 | President And Fellows Of Harvard College | Procédés d'identification de compositions qui modulent la protéine tyrosine kinase, ptp-bl |
WO2011094806A1 (fr) * | 2010-02-03 | 2011-08-11 | Monash University | Dosage de diagnostic et de pronostic pour le cancer du sein |
CA3070146A1 (fr) * | 2016-07-19 | 2018-01-25 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Virus oncolytiques ciblant stat3 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6080772A (en) * | 1995-06-07 | 2000-06-27 | Sugen, Inc. | Thiazole compounds and methods of modulating signal transduction |
WO1999023493A1 (fr) * | 1997-10-31 | 1999-05-14 | The Rockefeller University | Procedes d'identification d'agents modulant une activite de la leptine |
CA2220853A1 (fr) * | 1998-01-16 | 1999-07-16 | Hsc Research And Development Limited Partnership | Tyrosine phosphatase pour tissus lymphoides humains |
AU1543600A (en) * | 1998-12-11 | 2000-07-03 | Mcgill University | Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
JP2003501098A (ja) * | 1999-06-03 | 2003-01-14 | コールド スプリング ハーバー ラボラトリー | 基質捕捉性プロテインチロシンホスファターゼ |
EP1214060A2 (fr) * | 1999-09-10 | 2002-06-19 | Novo Nordisk A/S | Procede d'inhibition de la proteine tyrosine phosphatase 1b et/ou de la proteine tyrosine phosphatase de lymphocytes et/ou d'autres ptpases possedant un reste aps en position 48 |
-
2000
- 2000-11-27 CA CA002326952A patent/CA2326952A1/fr not_active Abandoned
-
2001
- 2001-11-27 AU AU2002220412A patent/AU2002220412A1/en not_active Abandoned
- 2001-11-27 WO PCT/CA2001/001679 patent/WO2002042489A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002220412A1 (en) | 2002-06-03 |
WO2002042489A1 (fr) | 2002-05-30 |
WO2002042489A9 (fr) | 2002-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ma et al. | Lysyl oxidase 3 is a dual-specificity enzyme involved in STAT3 deacetylation and deacetylimination modulation | |
McPhee et al. | Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family | |
Vitari et al. | WNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (protein kinase B)/Akt substrate | |
Woodford-Thomas et al. | Expression of a protein tyrosine phosphatase in normal and v-src-transformed mouse 3T3 fibroblasts | |
O'CONNELL et al. | The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5) | |
Karakashian et al. | Expression of neutral sphingomyelinase‐2 (NSMase‐2) in primary rat hepatocytes modulates IL‐β‐induced JNK activation | |
He et al. | ASK1 associates with troponin T and induces troponin T phosphorylation and contractile dysfunction in cardiomyocytes | |
Schneider et al. | Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN | |
Weng et al. | Transmembrane tyrosine phosphatase LAR induces apoptosis by dephosphorylating and destabilizing p130Cas | |
US5831009A (en) | Protein phosphotyrosine phosphatases PTP-D1 | |
US20020048782A1 (en) | Pyk2 related products and methods | |
Boratkó et al. | RACK1 is involved in endothelial barrier regulation via its two novel interacting partners | |
AU2011214254B2 (en) | Dual activity kinase domains and uses thereof | |
US6383734B1 (en) | Method to determine inhibition of PAK3 activation of Raf-1 | |
US5972674A (en) | Stimulus-inducible protein kinase complex and methods of use therefor | |
KR20080023729A (ko) | 미토겐-활성화 단백질 키나아제의 신규 인산화 자리, 변형단백질 및 적용 | |
US6514719B1 (en) | Methods for identifying compounds that alter kinase activity | |
CA2270911A1 (fr) | Materiels de proteine-kinase point de controle du cycle cellulaire, effecteur de chk1 mammalien et methodes | |
CA2326952A1 (fr) | Tyrosine-phosphatase de proteines de cellules t | |
AU2004296643B2 (en) | Use of enzymatic inhibitors of h-PRUNE for the prevention and treatment of the metastases of tumours overexpressing h-PRUNE | |
US6511825B1 (en) | Cell signaling polypeptides and nucleic acids | |
US20090181003A1 (en) | Regulation of S6 Kinsase Protein Activity and Related Methods | |
US8278263B2 (en) | Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and raptor | |
US7037677B2 (en) | Megakaryocytic protein tyrosine kinase I | |
Sephton | SHP-1 and PDK1 Form a Phosphotyrosine-Dependent Nucleo-Cytoplasmic Shuttling Complex: Implications for Differentiation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |